Andere Sprachen Yield10 Bioscience, Inc.

Aktien

A40A3X

US98585K8541

YTEN

Markt geschlossen - OTC Markets Andere Börsenplätze 20:02:17 20.06.2024			% 5 Tage	% 1. Jan.
1.28 ^USD	+0.79%		-9.86%	-77.71%

17.06.	Rothamsted Research erteilt Yield10 Bioscience eine exklusive, weltweite kommerzielle Lizenz für eine fortschrittliche Technologie zur Herstellung von Omega-3-Produkten in Camelina	CI
15.05.	Yield10 Bioscience, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina	17.06.
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina	17.06.
Yield10 Bioscience : Certificate of Incorporation/Bylaws Form 8 K	12.06.
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label	23.05.
Yield10 Bioscience, Inc.(OTCPK:YTEN) dropped from S&P TMI Index	20.05.
Earnings Flash (YTEN) YIELD10 BIOSCIENCE Posts Q1 Revenue $300,000	15.05.
Yield10 Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Yield10 Bioscience Announces First Quarter 2024 Financial Results	15.05.
Top Midday Decliners	15.05.
Yield10 Bioscience to Delist From Nasdaq; Shares Drop	15.05.
Yield10 Bioscience Announces Delisting from Nasdaq	15.05.
Yield10 Bioscience, Inc.(OTCPK:YTEN) dropped from NASDAQ Composite Index	15.05.
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split	01.05.
Yield10 Bioscience : 2024 Special Meeting of Stockholders	02.04.
Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01.04.
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results	01.04.
Yield10 Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024	28.03.
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada	26.03.
Yield10 Bioscience, Inc. Announces the Plant Biosafety Office of the Canadian Food Inspection Agency Clear Genome-edited E3902 Camelina for Planting in Canada	26.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Yield10 Bioscience, Inc.

Aktien

A40A3X

US98585K8541

YTEN

Andere Sprachen

Filter